Results of THRIVE treatent study show that ximelagatran is safe and effective against throbosis.
D000284:Administration, Oral; D001384:Azetidines / Q000009:adverse effects / Q000494:pharmacology*; D001596:Benzylamines; D006801:Humans; D011355:Prodrugs; D016032:Randomized Controlled Trials as Topic; D013917:Thrombin / Q000037:antagonists & inhibitors; D020246:Venous Thrombosis / Q000188:drug therapy*
D001384:Azetidines; D001596:Benzylamines; D011355:Prodrugs; C426686:ximelagatran; D013917:Thrombin